Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Accenture
McKinsey
Daiichi Sankyo
US Army
Covington
Cantor Fitzgerald
Johnson and Johnson

Generated: April 27, 2018

DrugPatentWatch Database Preview

BRETHINE Drug Profile

« Back to Dashboard

Which patents cover Brethine, and when can generic versions of Brethine launch?

Brethine is a drug marketed by Pharmacare and Ani Pharms Inc and is included in two NDAs.

The generic ingredient in BRETHINE is terbutaline sulfate. There are seven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.
Drug patent expirations by year for BRETHINE
Medical Subject Heading (MeSH) Categories for BRETHINE
Synonyms for BRETHINE
(+-)-5-(2-((1,1-Dimethylethyl)amino)-1-hydroxyethyl)-1,3-benzenediol
(+-)-Terbutaline
031T256
1-(3',5'-dihydroxyphenyl)-2-(t-butylamino)-ethanol
1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-
1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)- (9CI)
1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-, (+-)-
1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-(9CI)
1,3-Benzenediol, 5-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-
2-t-Butylamino-1-(3,5-dihydroxyphenyl)ethanol
23031-25-6
23031-32-5 (Sulfate)
46719-29-3
5- benzene-1,3-diol
5-(2-((1,1-DIMETHYLETHYL)AMINO)-1-HYDROXYETHYL)-1,3-BENZENEDIOL
5-(2-(tert-Butylamino)-1-hydroxyethyl)benzene-1,3-diol
5-[2-(tert-Butylamino)-1-hydroxyethyl]-1,3-benzenediol #
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol, 5
5-[2-(tert-butylamino)-1-oxidanyl-ethyl]benzene-1,3-diol
5-{2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl}benzene-1,3-diol
A816514
AB00053548
AB00053548_15
AC1L1KA2
ACM23031256
AK129818
AKOS015889885
alpha-[(tert-butylamino)methyl]-3,5-dihydroxybenzenemethanol
API0005740
Asthmasian
Asthmasian (TN)
AX8152612
BDBM25770
Benzyl alcohol, .alpha.-((t-butylamino)methyl)-3,5-dihydroxy-
Benzyl alcohol, alpha-((t-butylamino)methyl)-3,5-dihydroxy-
BPBio1_000663
BRD-A50157456-065-02-4
Brethaire
Brethaire (Salt/Mix)
Brethaire (TN)
Brethine (TN)
Brican
Bricanyl
Bricanyl (Salt/Mix)
Bricanyl (TN)
Bricar
Bricaril
Bricyn
BRN 2370513
BSPBio_000601
BSPBio_002066
C07129
CCG-205201
CHEBI:9449
CHEMBL1760
CTK8E4128
D08570
D0M8RC
DB00871
DivK1c_000078
DTXSID7021310
EINECS 245-385-8
FT-0654976
GTPL560
I01-3464
IDI1_000078
J-014950
KB-243251
KBio1_000078
KBio2_001510
KBio2_004078
KBio2_006646
KBio3_001566
KBioGR_001539
KBioSS_001510
KWD 2019
KWD-2019
L000594
Lopac0_001126
LS-29961
LS-7713
NCGC00016010-03
NCGC00016010-04
NCGC00016010-06
NCGC00089821-02
NINDS_000078
Oprea1_823972
OR055036
OR207698
OR341424
PDSP1_000158
PDSP2_000157
Prestwick0_000391
Prestwick1_000391
Prestwick2_000391
Prestwick3_000391
SBB063955
SBI-0051094.P004
SCHEMBL4391
SPBio_001453
SPBio_002522
Spectrum_001030
Spectrum2_001327
Spectrum3_000593
Spectrum4_000870
Spectrum5_001262
SR-01000000174
SR-01000000174-2
Terbutalin
Terbutalina
Terbutalina [DCIT]
terbutaline
Terbutaline (INN)
Terbutaline (sulfate de)
Terbutaline [INN:BAN]
Terbutaline sulfate
Terbutaline sulfate (Salt/Mix)
Terbutaline,(+/-)
Terbutalini sulfas
Terbutalino
Terbutalino [INN-Spanish]
Terbutalinum
Terbutalinum [INN-Latin]
TR-036208
VA11844
XWTYSIMOBUGWOL-UHFFFAOYSA-N

US Patents and Regulatory Information for BRETHINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacare BRETHINE terbutaline sulfate INJECTABLE;INJECTION 018571-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ani Pharms Inc BRETHINE terbutaline sulfate TABLET;ORAL 017849-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ani Pharms Inc BRETHINE terbutaline sulfate TABLET;ORAL 017849-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for BRETHINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ani Pharms Inc BRETHINE terbutaline sulfate TABLET;ORAL 017849-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Ani Pharms Inc BRETHINE terbutaline sulfate TABLET;ORAL 017849-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacare BRETHINE terbutaline sulfate INJECTABLE;INJECTION 018571-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Ani Pharms Inc BRETHINE terbutaline sulfate TABLET;ORAL 017849-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Healthtrust
Deloitte
Express Scripts
QuintilesIMS
Boehringer Ingelheim
Fuji
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.